Melissa J. Rose, DO

Dr. Rose’s clinical interests are general hematology/oncology, with particular interests in hemostasis and thrombosis, as well as bone marrow failure syndromes. She collaborates with the Department of Immunology at Nationwide Children’s to evaluate and address the needs of patients with persistent cytopenias and combined immunologic and hematologic dysfunction, as well as the Department of Neurology to evaluate and care for children who have had strokes. Her research interests involve assessing risks and possible preventative treatment for thrombosis in children with diabetes, open treatment protocols for idiopathic thrombocytopenic purpura (ITP), and an investigator-initiated collaboration with immunology regarding immunologic dysfunction in patients with ITP. Dr. Rose is currently a contributing site investigator for national registry for patients with severe neutropenia. Dr. Rose attended medical school at Philadelphia College of Osteopathic Medicine and received residency training from Children’s Hospital at Sinai in Baltimore. She completed her fellowship at Nationwide Children’s and is now the Associate Program Director for the Hematology/Oncology/BMT fellowship program.

Gender:

• Female

Languages Spoken:

• English

Medical School

• Philadelphia College of Osteopathic Medicine
  Date Completed: 06/30/2001

Internship

• Albert Einstein Montefiore Medical Center
  Date Completed: 06/30/2002

Residency

• Children's Hospital at Sinai
  Date Completed: 06/30/2005

Fellowship

• Nationwide Children's Hospital
  Date Completed: 06/30/2008

Department:

• Pediatrics

Section:

• Hematology & Oncology

Specialty:

• Pediatric Hematology Oncology
  

Date of Appointment at Nationwide Children’s Hospital:

• 07/01/2008

• Woods,Gary; Bajwa,Rajinder,PS; Rose,Melissa,J. 2014. Reduced intensity transplantation for congenital amegakaryocytic thrombocytopenia: Report of a case and review of the literature.  PEDIATRIC TRANSPLANTATION. Vol. 18, no. 1. (February): E31-E34.
• Woods,Gary; Bajwa,Rajinder,PS; Rose,Melissa,J. 2014. Reduced intensity transplantation for congenital amegakaryocytic thrombocytopenia: Report of a case and review of the literature.  PEDIATRIC TRANSPLANTATION. Vol. 18, no. 1. (February 1): E31-E34-E31-E34.
• Kime,Courtney; Klima,Jennifer; Rose,Melissa,J; O'Brien,Sarah,H. 2013. Patterns of Inpatient Care for Newly Diagnosed Immune Thrombocytopenia in US Children's Hospitals.  PEDIATRICS. Vol. 131, no. 5. (May 1): 880-885-880-885.
• Kime,Courtney; Klima,Jennifer; Rose,Melissa,J; O'Brien,Sarah,H. 2013. Patterns of Inpatient Care for Newly Diagnosed Immune Thrombocytopenia in US Children's Hospitals.  PEDIATRICS. Vol. 131, no. 5. (May): 880-885.
• 2013. Use of ultrasound to facilitate difficult lumbar puncture in the pediatric oncology population.  International Journal of Clinical and Experimental Medicine. Vol. 6, no. 2. (February 6).
• Bhalla, T, Martin D, Rehman S, Dewhirst E, Rose MJ, Guinipero T, Tobias J. 2013. Use of Ultrasound to facilitate difficult lumbar puncture in the pediatric oncology population.  Int J Clin Exp Med. Vol. 6, no. 2. (January): 149-152.
• Stenger MR, Rose MJ, Joshi MS, Rogers LK, Chicoine LG, Bauer JA, Nelin LD. 2010. Inhaled nitric oxide prevents 3-Nitrotyrosine formation in the lungs of neonatal mice exposed to >95% oxygen.  Lung. Vol. 188, no. 3. (June): 217-227.
• Stenger MR, Rose MJ, Joshi MS, Rogers LK, Chicoine LG, Bauer JA, Nelin LD. 2010. Inhaled nitric oxide prevents 3-Nitrotyrosine formation in the lungs of neonatal mice exposed to >95% oxygen.  Lung. Vol. 188, no. 3. (June 1): 217-227-217-227.
• Rose MJ, Stenger MR, Joshi MS, Welty SE, Bauer JA, Nelin LD. 2010. Inhaled nitric oxide decreases leukocyte trafficking in the neonatal mouse lung during exposure to >95% oxygen.  Pediatr Research. Vol. 67, no. 3. (March): 244-249.
• 2010. Inhaled Nitric Oxide Decreases Leukocyte Trafficking in the Neonatal Mouse Lung During Exposure to > 95% Oxygen.  PEDIATRIC RESEARCH. Vol. 67, no. 3. (March 1).
• Rose MJ, Nicol KK, Skeens MA, Gross TG, Kerlin BA. 2008. Congenital amegakaryocytic thrombocytopenia: the diagnostic importance of combining pathology with molecular genetics.  Pediatr Blood Cancer. Vol. 50, no. 6. (June): 1263-1265.
• Rose MJ, Nicol KK, Skeens MA, Gross TG, Kerlin BA. 2008. Congenital amegakaryocytic thrombocytopenia: the diagnostic importance of combining pathology with molecular genetics.  Pediatr Blood Cancer. Vol. 50, no. 6. (June 1): 1263-1265-1263-1265.
• Nicol KK, Swedan N, Moder P, Kahwash S, Rose MJ, Kerlin B. 2006. Hemolytic Anemia in a 5-Year-Old Child.  Lab Medicine. Vol. 37, no. 12. (January): 746-748.
• Nicol KK, Swedan N, Moder P, Kahwash S, Rose MJ, Kerlin B. 2006. Hemolytic Anemia in a 5-Year-Old Child.  Lab Medicine. Vol. 37, no. 12. (January 1): 746-748-746-748.
• 2004. Cerebral sinus venous thrombosis in children.  JOURNAL OF PAEDIATRICS AND CHILD HEALTH. Vol. 40, no. 1-2. (January 1).